[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-355955-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-355955-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","trmt6-mediated-m1a-modification-of-cdk9-mrna-is-a-dual-pronged-pathogenic-driver-for-hbv-related-hepatocellular-carcinoma","TRMT6-Mediated m1A Modification of CDK9 mRNA Is a Dual-Pronged Pathogenic Driver for HBV-Related Hepatocellular Carcinoma","","Hepatocellular carcinoma (HCC) is a major cause of death worldwide, driven in large part by hepatitis B virus (HBV) infection. The study investigates whether N1-methyladenosine (m1A) RNA modification contributes to HCC progression and HBV replication. Single-nucleus RNA sequencing of HCC and adjacent tissues shows elevated mRNA methylation in tumors, with increased m1A “writers/readers” and decreased “erasers.” TRMT6 is upregulated and linked to poor prognosis. TRMT6 knockdown reduces malignant phenotypes and tumorigenicity while suppressing HBV replication. Mechanistically, TRMT6-mediated m1A enhances CDK9 mRNA stability and translation, promotes HCC progression via downstream oncogenic effectors, and stimulates HBV replication through TARDBP phosphorylation at Ser254, increasing pgRNA transcription and repressing pgRNA splicing. The CDK9 inhibitor FIT-039 blocks these effects with no obvious toxicity, supporting TRMT6-m1A/CDK9 as a therapeutic target.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/trmt6-mediated-m1a-modification-of-cdk9-mrna-is-a-dual-pronged-pathogenic-driver-for-hbv-related-hepatocellular-carcinoma/355955/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/trmt6-mediated-m1a-modification-of-cdk9-mrna-is-a-dual-pronged-pathogenic-driver-for-hbv-related-hepatocellular-carcinoma/355955.png","ImageObject",300,407,{"name":42,"@type":43},"Ben ","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-08","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main research question regarding m1A and HBV-related HCC?","Question",{"text":63,"@type":64},"The study examines whether N1-methyladenosine (m1A) modification is associated with HCC progression and HBV replication, and how it may drive both processes.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What did single-nucleus RNA sequencing reveal in HCC tissues?",{"text":68,"@type":64},"It showed elevated mRNA methylation in HCC, including increased expression of m1A “writers” and “readers,” and decreased expression of m1A “erasers.”",{"name":70,"@type":61,"acceptedAnswer":71},"How does TRMT6-mediated m1A modification influence CDK9 and downstream effects?",{"text":72,"@type":64},"TRMT6-mediated m1A enhances the stability and translation efficiency of CDK9 mRNA, leading to HCC progression through downstream oncogenic effectors and promoting HBV replication via TARDBP phosphorylation at Ser254.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},355955,1790692678,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},2336478951081,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Advanced Science    \n[www.advancedscience.com](www.advancedscience.com)  \n RESEARCH ARTICLE   \nTRMT6-Mediated m1A Modification ofCDK9 mRNA Is a Dual-Pronged Pathogenic Driver for HBV-Related Hepatocellular Carcinoma  \nRui Zhang1, 2, 3  Dandan Zong4  Rui Liu5  Yubo Wang1, 2  Qingqing Gu1, 2  Yao Yao1, 2  Wenfang Zheng1, 2 Mengmeng Yuan1, 2  Simeng Wang1, 2  Rongrong Cui1, 2  Daxu Li6  Siwen Dang7  Peng Hou1, 2   \n1 Department of Endocrinology and Metabolism, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, P. R. China  2 International Joint Research Center for Tumor Precision Medicine of Shaanxi Province, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, P. R. China  3 Department of Infectious Diseases, Tangdu Hospital, The Fourth Military Medical University, Xi’an, P.R. China  4Yulin Hospital, The First Affiliated Hospital of Xi’an Jiaotong University, Yulin, P. R. China  5 Department of Radio-Oncology, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, P. R. China  6 Department of Stomatology, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, P. R. China  7 Department of Endocrinology and Metabolism, The Second Affiliated Hospital, Xi’an Jiaotong University, Xi’an, P. R. China  \nCorrespondence: Siwen Dang ([dangsiwen@stu.xjtu.edu.cn](dangsiwen@stu.xjtu.edu.cn))  Peng Hou (phou@xjtu.edu.cn)  \nReceived: 31 July 2025  Revised: 30 March 2026  Accepted: 7 April 2026  \nKeywords: CDK9| Hepatocellular carcinoma (HCC)| N1-methyladenosine (m1A)| TARDBP| TRMT6  \nABSTRACT  \nHepatocellular carcinoma (HCC) is a leading cause of death worldwide, with hepatitis B virus (HBV) infection being the major risk factor. Dysregulation of mRNA methylation contributes to tumorigenesis and virus replication. However, the association of N1-methyladenosine (m1A) modification with HCC progression and HBV replication remains unclear. Here, single-nucleus RNA sequencing (snRNA-seq) of 4 HCC and 7 adjacent tissues (2 from this study and 5 from the GSE242889) revealed elevated mRNA methylation inHCCs, with increased expression of m1A “writers” and “readers” and decreased expression of m1A “erasers”. Among them, m1A writer TRMT6 was up-regulated in HCC and correlated with poor patient prognosis. TRMT6 knockdown strikingly restrained the malignant phenotypes and tumorigenicity of HCC cells as well as HBV replication. Mechanistically, TRMT6-mediated m1A modification enhanced the stability and translation efficiency of cyclin-dependent kinase 9 (CDK9) mRNA. Elevated CDK9 facilitated HCC progression by up-regulating its downstream oncogenic effectors, and stimulated HBV replication via TARDBP phosphorylation at Ser254 to enhance pgRNA transcription and repress pgRNA splicing. CDK9 inhibitor FIT- 039 abrogated these effects without obvious toxicity. Thus, TRMT6-mediated m1A modification dually drives HCC malignancy and HBV replication, representing a promising therapeutic target, and CDK9 inhibition may constitute an effective strategy for HBV-related HCC.  \n1  Introduction  \nHepatocellular carcinoma (HCC) is a prevalent malignancy anda cause of death globally, which accounts for 85%–90% of all  \nliver cancer cases [1] . As reported in 2020, the incidence and mortality of HCC rank sixth and third globally [2] . In China, the incidence of HCC ranks fourth in the total and is also the second leading cause of cancer-related deaths [3], with a 5-year relative  \n\n| Rui Zhang and Dandan Zong contributed equally to this work.\u003Cbr>|\n| --- |\n| This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.\u003Cbr>© 2026 The Author(s). Advanced Science published by Wiley-VCH GmbH |\n\nAdvanced Science, 2026; 0:e14172  \n[https://doi.org/10.1002/advs.202514172](https://doi.org/10.1002/advs.202514172)  \n1 of 23  \nsurvival rate is 14.4%[4]. HCC is highly aggressive and has a high mor","cbCaicwmgreHcXp3","https://ap.wps.com/l/cbCaicwmgreHcXp3","pdf",13868321,23,"English","# Abstract\n## Introduction","[{\"question\":\"What is the main research question regarding m1A and HBV-related HCC?\",\"answer\":\"The study examines whether N1-methyladenosine (m1A) modification is associated with HCC progression and HBV replication, and how it may drive both processes.\"},{\"question\":\"What did single-nucleus RNA sequencing reveal in HCC tissues?\",\"answer\":\"It showed elevated mRNA methylation in HCC, including increased expression of m1A “writers” and “readers,” and decreased expression of m1A “erasers.”\"},{\"question\":\"How does TRMT6-mediated m1A modification influence CDK9 and downstream effects?\",\"answer\":\"TRMT6-mediated m1A enhances the stability and translation efficiency of CDK9 mRNA, leading to HCC progression through downstream oncogenic effectors and promoting HBV replication via TARDBP phosphorylation at Ser254.\"}]","TRMT6-Mediated m1A Modification of CDK9 mRNA Is a Dual-Pronged Pathogenic Driver for HBV-Related Hepatocellular Carcinoma | PDF",1790121955,58,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f6c79241802b6f6cd7133511805ec29c.webp",983,1283,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c067bd8a94e160588334bcd4420c6b9d.webp",982,1281,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e59485d23e2349f6c6043cbcdf13aa7e.webp",981,1280,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e0c92583d1d8911b32abeac1205b3aef.webp",980,1279]